Silencing of TRPC1 in NRVMs with siRNA has been shown to prevent cardiac hypertrophy induced by endothelin-1, angiotensin-II, and phenylephrine (Ohba et al., 2007). This evidence concerns the gene TRPC1 and cardiac hypertrophy.